Infertility
Conditions
Brief summary
To compare the number of MII oocytes retrieved after final oocyte maturation with a 2-shot sequential administration of CFA or a unique administration of CFA followed by daily rFSH for controlled ovarian stimulation in patients undergoing elective fertility preservation.
Detailed description
Total number of oocytes retrieved, Endocrine profile on the day of trigger (FSH, LH, estradiol, progesterone), Incidence of OHSS, Quality of life questionnaire “FertiQoL”, Length of stimulation
Interventions
DRUGElonva 100 micrograms solution for injection
DRUGCerazet 75 microgramos comprimidos recubiertos con película
Sponsors
Santiago Dexeus Font Fundacio Privada
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the number of MII oocytes retrieved after final oocyte maturation with a 2-shot sequential administration of CFA or a unique administration of CFA followed by daily rFSH for controlled ovarian stimulation in patients undergoing elective fertility preservation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total number of oocytes retrieved, Endocrine profile on the day of trigger (FSH, LH, estradiol, progesterone), Incidence of OHSS, Quality of life questionnaire “FertiQoL”, Length of stimulation | — |
Countries
Spain
Outcome results
None listed